Home › Drug Codes › J Codes › J9362 · Yondelis
Updated October 1st, 2026

Yondelis J Code: J9362

Injection, trabectedin, 0.01 mg

Login to unlock all benchmarks
Medicare Payment Limit ?
$41.844
/ HCPCS billing unit
APC Payment Limit ?
$41.844
/ HCPCS billing unit · APC 0972
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
1
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, trabectedin, 0.01 mg
HCPCS Added Date October 1, 2026
Manufacturer Janssen
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Injection, Powder, Lyophilized, For Solution

About Yondelis

Yondelis is a medication aligned to the HCPCS J Code: J9362 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by Janssen.

Manufacturers, reach out to us to add more information.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
59676-0610-01 Yondelis Janssen Products, LP 100 1 MG / 20 ML
Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

Yondelis Pricing & Reimbursement

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q4 2026

Yondelis CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

Yondelis Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

unresectable or metastatic liposarcoma or leiomyosarcoma
Drug Class
Alkylating Activity [MoA]Alkylating Drug [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Yondelis billing and coding guide?
Our team has not identified a manufacturer-published source of billing and coding information for Yondelis.
Are there any available Yondelis patient assistance programs?
Our team has not identified a manufacturer-published source of patient assistance information for Yondelis.
Where can I find Yondelis prescribing information?
Yondelis prescribing information can be found at the link below. Please reach out to us if you believe this information to be inaccurate or out of date. Visit Here →
Where can I find Yondelis side effect information?
Our team has not yet identified a source of side effects information for Yondelis. Please check back in a few weeks.
Does billing Yondelis require JZ/JW wastage modifiers?
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.